Dr. Ruth M. Carrico, DNP, APRN, a family nurse practitioner and infectious disease specialist, discussed the updated FLUBLOK vaccine labeling, which includes safety for pregnant women, in a recent interview.
Carrico expressed excitement about this latest information, especially given his experience treating pregnant women with influenza. FLUBLOK, a recombinant influenza vaccine, is currently included in the Centers for Disease Control and Prevention and American College of Obstetricians and Gynecologists’ recommendations for pregnant and pregnant patients. This addition expands the range of vaccines available and allows health care providers more flexibility when recommending influenza vaccination for this vulnerable population.
Influenza infection during pregnancy has risks that health care providers must be aware of. Physiological changes make pregnant women more vulnerable and the effects of influenza infection can be severe. Infection can cause respiratory and cardiovascular disease, and in worst cases, pneumonia, hospitalization, and even death. These complications can also put the fetus at risk.
Carrico also discussed the results of a study evaluating FLUBLOK in pregnant women, noting that when FLUBLOK was compared to a standard influenza vaccine, the study found no increased risk of adverse events such as pregnancy complications, birth outcomes, or neonatal problems. He emphasized that it was not shown. This is reassuring for health care providers because it indicates that vaccination should not be withheld if influenza protection is needed in this population.
Carrico concluded by saying that the use of FLUBLOK simplifies the vaccination process, especially for patients who have concerns such as avoiding egg-based vaccines. More options allow for better patient education, encourage vaccination, and ultimately help avoid preventable complications in pregnant women, especially respiratory diseases. A broader toolkit will enable healthcare professionals to make stronger recommendations and ensure improved patient outcomes.
